Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-125,369
Closed -$222K 2869
2025
Q1
$222K Buy
+125,369
New +$226K ﹤0.01% 2370
2023
Q2
Sell
-95,457
Closed -$123K 2636
2023
Q1
$123K Buy
95,457
+25,657
+37% +$46.7K ﹤0.01% 2481
2022
Q4
$105K Sell
69,800
-67,907
-49% -$114K ﹤0.01% 2784
2022
Q3
$306K Sell
137,707
-105,030
-43% -$319K ﹤0.01% 2943
2022
Q2
$718K Buy
+242,737
New +$899K ﹤0.01% 2625
2021
Q1
Sell
-288,866
Closed -$5.86M 2612
2020
Q4
$5.86M Buy
+288,866
New +$4.84M 0.03% 511

Other funds holding GAN

Marshall Wace's GAN Position: Q2 2025 in Review

Marshall Wace sold out of GAN Ltd (GAN) in Q2 2025, closing a stake of 125,369 shares — an estimated $222K sold.

Marshall Wace first reported a position in GAN in Q4 2020 and held it in 6 quarters. The position peaked at $5.86M in Q4 2020. 1 fund tracked by Wall St. Rank holds GAN as of Q2 2025.

  • Marshall Wace reported no remaining GAN Ltd position as of Q2 2025 after selling out during the quarter.
  • Marshall Wace sold 125,369 GAN Ltd shares in Q2 2025, an estimated $222K.
  • Marshall Wace first reported a position in GAN Ltd in Q4 2020 and held it in 6 quarters.
  • Marshall Wace's GAN Ltd position peaked at $5.86M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held GAN Ltd as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.